Vivos Therapeutics Inc (VVOS) — Financial Flexibility Index
Vivos Therapeutics Inc (VVOS) has a Financial Flexibility Index of -0.11x as of June 2026. Free cash flow of $-3.13 Million (operating CF $-3.15 Million minus capex $18.00K) represents 0% of total liabilities ($28.13 Million). Check tangible equity quality of Vivos Therapeutics Inc to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vivos Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Vivos Therapeutics Inc across 8 annual periods. For the full cash flow conversion analysis, see VVOS cash flow metrics.
Annual Financial Flexibility Index for Vivos Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Vivos Therapeutics Inc. Explore Vivos Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.48x | $-12.92 Million | $-15.26 Million | $26.70 Million | ▲ +70.7% |
| 2024 | -1.65x | $-12.12 Million | $-12.69 Million | $7.33 Million | ▼ -53.2% |
| 2023 | -1.08x | $-11.14 Million | $-11.95 Million | $10.32 Million | ▲ +48.4% |
| 2022 | -2.09x | $-18.66 Million | $-19.59 Million | $8.92 Million | ▼ -27.8% |
| 2021 | -1.64x | $-13.34 Million | $-15.73 Million | $8.15 Million | ▼ -147.6% |
| 2020 | -0.66x | $-5.56 Million | $-5.68 Million | $8.41 Million | ▼ -34.3% |
| 2019 | -0.49x | $-5.16 Million | $-5.34 Million | $10.49 Million | ▲ +59.1% |
| 2018 | -1.20x | $-4.06 Million | $-5.31 Million | $3.38 Million | — |